A slow-growing blood cancer affecting white blood cells in the bone marrow and blood.
Medical records documenting your current treatment are central to establishing which rating level applies. For a 100% rating, records should show that a peripheral blood or bone marrow stem cell transplant has been performed or scheduled, or that you are receiving continuous myelosuppressive or immunosuppressive therapy. Hospital admission dates and discharge summaries, treatment start and end dates, and oncology notes confirming the ongoing nature of therapy all directly support this level.
For a 60% rating, records should show that you are receiving intermittent myelosuppressive therapy, molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment, and that you are not in apparent remission. Oncology or hematology notes describing treatment schedules, prescription records, and lab results reflecting disease activity are relevant here.
For a 30% rating, records should show you are in apparent remission while maintained on continuous molecularly targeted therapy with tyrosine kinase inhibitors. Hematology notes confirming remission status and documentation of ongoing tyrosine kinase inhibitor prescriptions support this level.
Statements from you describing how treatment affects your ability to work and carry out daily activities can also help VA understand the full impact of your condition.
Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.
